Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.17 Million USD | 374.66% |
| 2022 | 247.88 Thousand USD | 115.75% |
| 2021 | -1.57 Million USD | -198.91% |
| 2020 | 1.59 Million USD | 108.21% |
| 2019 | -19.38 Million USD | -137.05% |
| 2018 | -8.17 Million USD | -497.64% |
| 2017 | -1.36 Million USD | -424.91% |
| 2016 | -260.7 Thousand USD | 77.43% |
| 2015 | -1.15 Million USD | 39.21% |
| 2014 | -1.9 Million USD | -16.51% |
| 2013 | -1.63 Million USD | -9.88% |
| 2012 | -1.48 Million USD | 40.55% |
| 2011 | -2.49 Million USD | -434.35% |
| 2010 | -467.26 Thousand USD | -1076.43% |
| 2009 | -39.71 Thousand USD | -177.97% |
| 2008 | -14.28 Thousand USD | 83.85% |
| 2007 | -88.5 Thousand USD | -637.5% |
| 2006 | -12 Thousand USD | -20.55% |
| 2005 | -9954.00 USD | 83.83% |
| 2004 | -61.54 Thousand USD | 81.57% |
| 2003 | -333.9 Thousand USD | 0.0% |
| 2001 | -6.12 Million USD | -330.94% |
| 2000 | 2.65 Million USD | 25.59% |
| 1999 | 2.11 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -363.43 Thousand USD | 2.88% |
| 2024 Q1 | -374.2 Thousand USD | 5.3% |
| 2023 Q2 | -326.03 Thousand USD | -82.46% |
| 2023 Q1 | -178.68 Thousand USD | -234.53% |
| 2023 FY | 1.17 Million USD | 374.66% |
| 2023 Q4 | -395.16 Thousand USD | -119.03% |
| 2023 Q3 | 2.07 Million USD | 736.89% |
| 2022 Q3 | 483.29 Thousand USD | 349.39% |
| 2022 FY | 247.88 Thousand USD | 115.75% |
| 2022 Q4 | 132.82 Thousand USD | -72.52% |
| 2022 Q2 | -193.79 Thousand USD | -11.09% |
| 2022 Q1 | -174.44 Thousand USD | -109.18% |
| 2021 Q1 | -2.36 Million USD | -116.2% |
| 2021 Q4 | 1.9 Million USD | 22.6% |
| 2021 FY | -1.57 Million USD | -198.91% |
| 2021 Q3 | 1.55 Million USD | 159.04% |
| 2021 Q2 | -2.62 Million USD | -10.91% |
| 2020 FY | 1.59 Million USD | 108.21% |
| 2020 Q4 | 14.61 Million USD | 242.83% |
| 2020 Q3 | -10.23 Million USD | -213.21% |
| 2020 Q2 | 9.03 Million USD | 187.44% |
| 2020 Q1 | -10.33 Million USD | -4.96% |
| 2019 Q1 | -3.08 Million USD | -88.69% |
| 2019 Q4 | -9.84 Million USD | -2688.49% |
| 2019 FY | -19.38 Million USD | -137.05% |
| 2019 Q2 | -1.67 Million USD | 45.89% |
| 2019 Q3 | -353.23 Thousand USD | 78.86% |
| 2018 Q3 | -2.39 Million USD | 18.33% |
| 2018 Q1 | -1.21 Million USD | 83.91% |
| 2018 Q2 | -2.93 Million USD | -141.04% |
| 2018 Q4 | -1.63 Million USD | 31.63% |
| 2018 FY | -8.17 Million USD | -497.64% |
| 2017 Q4 | -7.56 Million USD | -5958.75% |
| 2017 FY | -1.36 Million USD | -424.91% |
| 2017 Q3 | -124.78 Thousand USD | -114.59% |
| 2017 Q2 | 855.11 Thousand USD | -84.34% |
| 2017 Q1 | 5.46 Million USD | 995.2% |
| 2016 Q2 | 68.92 Thousand USD | -51.98% |
| 2016 FY | -260.7 Thousand USD | 77.43% |
| 2016 Q4 | -610.09 Thousand USD | -545.42% |
| 2016 Q1 | 143.53 Thousand USD | 116.83% |
| 2016 Q3 | 136.97 Thousand USD | 98.74% |
| 2015 FY | -1.15 Million USD | 39.21% |
| 2015 Q2 | 6775.00 USD | 101.91% |
| 2015 Q3 | 46.51 Thousand USD | 586.58% |
| 2015 Q4 | -852.83 Thousand USD | -1933.43% |
| 2015 Q1 | -355.62 Thousand USD | 77.44% |
| 2014 Q2 | 102.46 Thousand USD | 116.44% |
| 2014 FY | -1.9 Million USD | -16.51% |
| 2014 Q4 | -1.57 Million USD | -1560.54% |
| 2014 Q3 | 107.91 Thousand USD | 5.32% |
| 2014 Q1 | -623.06 Thousand USD | 30.52% |
| 2013 Q4 | -896.74 Thousand USD | -2735.1% |
| 2013 Q3 | -31.63 Thousand USD | 90.97% |
| 2013 FY | -1.63 Million USD | -9.88% |
| 2013 Q1 | -376.13 Thousand USD | 13.1% |
| 2013 Q2 | -350.27 Thousand USD | 6.87% |
| 2012 Q3 | -417.35 Thousand USD | -14.55% |
| 2012 FY | -1.48 Million USD | 40.55% |
| 2012 Q4 | -432.81 Thousand USD | -3.7% |
| 2012 Q1 | -269.84 Thousand USD | 62.99% |
| 2012 Q2 | -364.33 Thousand USD | -35.02% |
| 2011 Q2 | -720.38 Thousand USD | -211.54% |
| 2011 Q4 | -729.12 Thousand USD | 10.66% |
| 2011 Q3 | -816.11 Thousand USD | -13.29% |
| 2011 Q1 | -231.23 Thousand USD | 19.94% |
| 2011 FY | -2.49 Million USD | -434.35% |
| 2010 FY | -467.26 Thousand USD | -1076.43% |
| 2010 Q4 | -288.81 Thousand USD | -373.63% |
| 2010 Q3 | -60.97 Thousand USD | 45.37% |
| 2010 Q2 | -111.61 Thousand USD | -1806.39% |
| 2010 Q1 | -5855.00 USD | 65.18% |
| 2009 Q3 | -13.77 Thousand USD | -101.09% |
| 2009 Q4 | -16.81 Thousand USD | -22.04% |
| 2009 Q1 | -2542.00 USD | 67.09% |
| 2009 FY | -39.71 Thousand USD | -177.97% |
| 2009 Q2 | -6852.00 USD | -169.55% |
| 2008 Q1 | -10 Thousand USD | -106.9% |
| 2008 Q3 | -22.52 Thousand USD | -186.66% |
| 2008 Q4 | -7725.00 USD | 65.7% |
| 2008 FY | -14.28 Thousand USD | 83.85% |
| 2008 Q2 | 25.98 Thousand USD | 359.88% |
| 2007 FY | -88.5 Thousand USD | -637.5% |
| 2007 Q3 | -15 Thousand USD | 90.32% |
| 2007 Q2 | -155 Thousand USD | -144.09% |
| 2007 Q1 | -63.5 Thousand USD | -6250.0% |
| 2007 Q4 | 145 Thousand USD | 1066.67% |
| 2006 Q2 | -1000.00 USD | 88.89% |
| 2006 Q1 | -9000.00 USD | -800.9% |
| 2006 FY | -12 Thousand USD | -20.55% |
| 2006 Q3 | -1000.00 USD | 0.0% |
| 2006 Q4 | -1000.00 USD | 0.0% |
| 2005 FY | -9954.00 USD | 83.83% |
| 2005 Q2 | -6722.00 USD | -521.26% |
| 2005 Q3 | -1151.00 USD | 82.88% |
| 2005 Q4 | -999.00 USD | 13.21% |
| 2005 Q1 | -1082.00 USD | 95.32% |
| 2004 Q4 | -23.13 Thousand USD | -164.48% |
| 2004 Q2 | -12.2 Thousand USD | 30.09% |
| 2004 Q3 | -8749.00 USD | 28.3% |
| 2004 Q1 | -17.45 Thousand USD | -256.01% |
| 2004 FY | -61.54 Thousand USD | 81.57% |
| 2003 FY | -333.9 Thousand USD | 0.0% |
| 2003 Q3 | -2000.00 USD | 0.0% |
| 2003 Q1 | -1000.00 USD | 0.0% |
| 2003 Q4 | -4903.00 USD | -145.15% |
| 2001 Q3 | -3.68 Million USD | -1287.1% |
| 2001 Q4 | -2.79 Million USD | 24.18% |
| 2001 FY | -6.12 Million USD | -330.94% |
| 2001 Q2 | 310 Thousand USD | 675.0% |
| 2001 Q1 | 40 Thousand USD | -96.83% |
| 2000 FY | 2.65 Million USD | 25.59% |
| 2000 Q2 | 360 Thousand USD | -7.69% |
| 2000 Q3 | 640 Thousand USD | 77.78% |
| 2000 Q4 | 1.26 Million USD | 96.88% |
| 2000 Q1 | 390 Thousand USD | 0.0% |
| 1999 FY | 2.11 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | 110.96% |
| Arem Pacific Corporation | -53.66 Thousand USD | 2292.448% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | 1094.816% |
| BioCorRx Inc. | -3.76 Million USD | 131.235% |
| Bionik Laboratories Corp. | -4.94 Million USD | 123.789% |
| Banyan Corp. | -5.48 Million USD | 121.459% |
| Clearday, Inc. | -14.3 Million USD | 108.223% |
| Dental Patient Care America, Inc. | 8974.00 USD | -13011.199% |
| Quantum Medical Transport, Inc. | 222.84 USD | -527901.705% |
| Empower Clinics Inc. | -2826.87 USD | 41721.971% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | 114.399% |
| Selectis Health, Inc. | -3.97 Million USD | 129.63% |
| HealthLynked Corp. | -1.01 Million USD | 216.241% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | 142.2% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | 1554.171% |
| Comjoyful International Company | -20.62 Thousand USD | 5804.446% |
| Medical Facilities Corporation | 18.5 Million USD | 93.641% |
| MedSmart Group Inc. | -76.23 Thousand USD | 1643.303% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | 247.355% |
| Nova Leap Health Corp. | -1.05 Million USD | 211.56% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | 498.407% |
| PAO Group, Inc. | 235.5 Thousand USD | -399.6% |
| Primemd Inc. | 3.14 Million USD | 62.531% |
| Raffles Medical Group Ltd | 68.31 Million USD | 98.278% |
| Ryman Healthcare Limited | 2.85 Million USD | 58.774% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 27895.866% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | 129.704% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | 199.598% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | 244.191% |
| Veltex Corporation | -1.06 Million USD | 210.68% |
| World Financial Holding Group | -28.42 Thousand USD | 4239.165% |
| Xcelerate Inc. | -2.75 Million USD | 142.775% |